| References |
|
|
Ashford JW and
Mortimer JA
(2002)
Non-familial Alzheimer's disease is mainly due to genetic factors.
Journal of Alzheimer's Disease
4(3):
169–177.
|
|
|
Bertram L,
Blacker D,
Mullin K et al.
(2000)
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.
Science
290(5500):
2302–2303.
|
|
|
ePath
Bertram L,
McQueen M et al.
(2007) The Alzgene database. Alzheimer Research Forum.
http://www.alzgene.org accessed on 10th September 2007.
|
|
|
Blacker D,
Bertram L et al.
(2003)
Results of a high-resolution genome screen of 437 Alzheimer's disease families.
Human Molecular Genetics
12(1):
23–32.
|
|
|
Blomqvist ME,
Reynolds C et al.
(2006)
Towards compendia of negative genetic association studies: an example for Alzheimer disease.
Human Genetics
119(1–2):
29–37.
|
|
|
Chalmers K,
Wilcock GK et al.
(2003)
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Neuropathology and Applied Neurobiology
29(3):
231–238.
|
|
|
Chen K,
Reiman EM et al.
(2007)
Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
American Journal of Psychiatry
164(6):
916–921.
|
|
|
Coon KD,
Myers AJ et al.
(2007)
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
Journal of Clinical Psychiatry
68(4):
613–618.
|
|
|
Curtis D,
North BV et al.
(2001)
A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease.
Annals of Human Genetics
65(Pt 5):
473–481.
|
|
|
Daw EW,
Payami H et al.
(2000)
The number of trait loci in late-onset Alzheimer disease.
American Journal of Human Genetics
66(1):
196–204.
|
|
|
Ertekin-Taner N,
Graff-Radford N et al.
(2000)
Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
Science
290(5500):
2303–2304.
|
|
|
Farrer LA,
Bowirrat A et al.
(2003)
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community.
Human Molecular Genetics
12(4):
415–422.
|
|
|
Ferri CP,
Prince M et al.
(2005)
Global prevalence of dementia: a Delphi consensus study.
Lancet
366(9503):
2112–2117.
|
|
|
Gatz M,
Reynolds CA et al.
(2006)
Role of genes and environments for explaining Alzheimer disease.
Archives of General Psychiatry
63(2):
168–174.
|
|
|
Gordon D,
Haynes C et al.
(2006)
Increase in linkage information by stratification of pedigree data into gold-standard and standard diagnoses: application to the NIMH Alzheimer Disease Genetics Initiative Dataset.
Human Heredity
61(2):
97–103.
|
|
|
Hamshere ML,
Holmans PA et al.
(2007)
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease.
Human Molecular Genetics
16(22):
2703–2712.
|
|
|
Hardy J and
Selkoe DJ
(2002)
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Science
297(5580):
353–356.
|
|
|
Holmans P,
Hamshere M et al.
(2005)
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease.
American Journal of Medical Genetics Part B: Neuropsychiatry Genetics
135(1):
24–32.
|
|
|
Holtzman DM,
Bales KR et al.
(2000)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the USA
97(6):
2892–2897.
|
|
|
Ioannidis JP,
Ntzani EE et al.
(2001)
Replication validity of genetic association studies.
Nature Genetics
29(3):
306–309.
|
|
|
Kehoe PG
(2003)
The renin-angiotensin-aldosterone system and Alzheimer s disease?
Journal of the Renin–Angiotensin–Aldosterone System
4(2):
80–93.
|
|
|
Lee JH,
Cheng R et al.
(2006)
Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease.
Archives of Neurology
63(11):
1591–1598.
|
|
|
Lee JH,
Mayeux R et al.
(2004)
Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.
Molecular Psychiatry
9(11):
1042–1051.
|
|
|
Li YJ,
Scott WK et al.
(2002)
Age at onset in two common neurodegenerative diseases is genetically controlled.
American Journal of Human Genetics
70(4):
985–993.
|
|
|
Love S
(2004)
Contribution of cerebral amyloid angiopathy to Alzheimer's disease.
Journal of Neurology Neurosurgery and Psychiatry
75(1):
1–4.
|
|
|
Lowin A,
Knapp M et al.
(2001)
Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding.
International Journal of Geriatric Psychiatry
16(12):
1143–1148.
|
|
|
Miners JS,
Van Helmond Z et al.
(2006)
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
Journal of Neuropathology and Experimental Neurology
65(10):
1012–1021.
|
|
|
Myers A,
Holmans P et al.
(2000)
Susceptibility locus for Alzheimer's disease on chromosome 10.
Science
290(5500):
2304–2305.
|
|
|
Myers A,
Wavrant De-Vrieze F et al.
(2002)
Full genome screen for Alzheimer disease: stage II analysis.
American Journal of Medical Genetics
114(2):
235–244.
|
|
|
Olson JM,
Goddard KA et al.
(2002)
A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region.
American Journal of Human Genetics
71(1):
154–161.
|
|
|
Pericak-Vance MA,
Bass MP et al.
(1997)
Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
JAMA
278(15):
1237–1241.
|
|
|
Pericak-Vance MA,
Grubber J et al.
(2000)
Identification of novel genes in late-onset Alzheimer's disease.
Experimental Gerontology
35(9–10):
1343–1352.
|
|
|
Pritchard JK and
Cox NJ
(2002)
The allelic architecture of human disease genes: common disease-common variant or not?
Human Molecular Genetics
11(20):
2417–2423.
|
|
|
Reiman EM,
Webster JA et al.
(2007)
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
Neuron
54(5):
713–720.
|
|
|
Roses AD
(1998)
Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases.
American Journal of Medical Genetics
81(1):
49–57.
|
|
|
Sadowski MJ,
Pankiewicz J et al.
(2006)
Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
Proceedings of the National Academy of Sciences of the USA
103(49):
18787–18792.
|
|
|
Scott WK,
Hauser ER et al.
(2003)
Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.
American Journal of Human Genetics
73(5):
1041–1051.
|
|
|
Sillen A,
Forsell C et al.
(2006)
Genome scan on Swedish Alzheimer's disease families.
Molecular Psychiatry
11(2):
182–186.
|
|
|
Stuck AE,
Rubenstein LZ et al.
(1998)
Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity.
BMJ
316(7129):
469; author reply 470–471.
|
|
|
Tang JL and
Liu JL
(2000)
Misleading funnel plot for detection of bias in meta-analysis.
Journal of Clinical Epidemiology
53(5):
477–484.
|
|
|
Ulery PG,
Beers J et al.
(2000)
Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease.
Journal of Biological Chemistry
275(10):
7410–7415.
|
| Further Reading |
|
|
Bertram L et al.
(2004)
Alzheimer's disease: one disorder, too many genes?
Human Molecular Genetics
13 Spec No 1:
R135–R141.
|
|
|
Dewji NN
(2005)
The structure and functions of the presenilins.
Cellular and Molecular Life Sciences
62(10):
1109–1119.
|
|
|
Kamboh MI
(2004)
Molecular genetics of late-onset Alzheimer's disease.
Annals of Human Genetics
68(Pt 4):
381–404.
|
|
|
Myers AJ et al.
(2001)
The genetics of late-onset Alzheimer's disease.
Current Opinion in Neurology
14(4):
433–440.
|
|
|
Selkoe DJ
(2000)
The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins.
Neurologic Clinics
18(4):
903–922.
|
|
|
Selkoe DJ
(2004)
Alzheimer disease: mechanistic understanding predicts novel therapies.
Annals of Internal Medicine
140(8):
627–638.
|
|
|
Sisodia SS et al.
(2001)
Gamma-secretase: never more enigmatic.
Trends in Neuroscience
24(suppl. 11):
S2–6.
|
|
|
St George-Hyslop PH
(2000)
Molecular genetics of Alzheimer's disease.
Biological Psychiatry
47(3):
183–199.
|
|
|
Tanzi RE et al.
(2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
Cell
120(4):
545–555.
|
